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ABSTRACT 
Pseudomonas aeruginosa is an opportunistic pathogen that may cause serious infections, 
ranging from localized skin infections to life-threatening systemic diseases.It is one of the 
resistant bacteria whichleads to failure in the treatment.New treatment strategies are urgently 
needed for the treatment of infections caused by resistant bacteria. Researchers are interested 
in Lactobacillus species because of their antimicrobial effective metabolites.The aim of this 
study was comparing the antibacterial activity of lactobacilli metabolites loaded chitosan and 
Pluronic F127 hydrogel formulations. Metabolites loaded hydrogel formulations were 
prepared by adding 20 µl of supernatant into the polymer solutions.The antimicrobial 
activities of two hydrogel formulations were investigated against P. aeruginosa using Agar 
Spot Method.Metabolites loaded chitosan hydrogel formulations were found to be effective 
against P. aeruginosa. No antibacterial activity was observed for metabolites loaded Pluronic 
  
F127 hydrogel formulations. When we compare these two hydrogel formulations, we 
observed that hydrogel formulation prepared by using chitosan released effective 
metabolitesbut Pluronic F127 hydrogel formulation couldn’t release antibacterial effective 
metabolites.The antibacterial effect of metabolites loaded chitosan hydrogel formulation 
suggests that this formulation could be used as an alternative treatment option in P. 
aeruginosa skin infections.However, further investigations are needed to develop a 
pharmaceutical product. 





Antibiotic resistance is a serious public health problem that threatens the whole world. Day 
by day, new multi-resistant microorganisms have increasingly been reported from different 
regions of the world. Failure in the treatment of these resistant bacteria leads scientists to 
investigate alternative treatment options1-3. 
Lactobacillus genus, which is grouped among lactic acid bacteria, comprises of Gram-
positive, facultative anaerobic or microaerophilic, non-spore-forming, rod-shaped bacteria. 
These bacteria produce lactic acid as the major metabolic end-product of carbohydrate 
fermentation. Some groups of them also produce various amounts of compounds such as 
acetic acid, carbon dioxide, and ethyl alcohol4-5. Lactobacilli are the normal flora members of 
the human body and they commonly found in the mouth, vagina, and intestines6. Owing to 
their metabolites and antagonistic effects, they protect the human body from pathogens7. In a 
healthy premenopausal woman, the dominance of lactobacilli in the vagina is protective 
against the colonization of pathogenic microorganisms8. In recent years, the number of 
studies reporting the beneficial effects of flora microorganisms on human health has 
increased. The genus Lactobacillus has taken considerable attention because of their 
antimicrobial, immunomodulatory, anti-inflammatory and anti-carcinogenic activities. These 
microorganisms have been the subject of many investigations to find out whether they can be 
used as an alternative for the treatment of diseases3, 9-12. 
Chitosan, a deacetylated derivative of chitin, is a cationic polymer that consists of a long 
chain formed by a combination of β-1,4-D-glucosamine (deacetylated unit) and N-acetyl-D-
glucosamine (acetylated unit) by linking with β (1–4) glycosidic bonds. As a natural polymer, 
it demonstrates incredible properties such as biocompatibility, biodegradability, non-toxicity, 
antimicrobial activity, and adsorption capability. Therefore, it has been extensively studied 
for its use in many fields. Chitosan is also widely used as a wound dressing due to its 
excellent hemostatic properties and antimicrobial activities. Its antimicrobial activity has 
been explained by several theories. The most accepted hypothesis is that its action on bacteria 
would occur by the loss of its intercellular components. Due to its positive charge, it binds to 
the bacterial membrane causing a change in permeability and the output of its intercellular 
components, thus leading to cell death. The antimicrobial activity of chitosan was observed 
against a wide variety of microorganisms, including fungi, algae, and bacteria, being more 
active against Gram-positive bacteria than Gram-negative ones13-15.  
  
Poloxamers, poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) triblock 
copolymers (PEO–PPO–PEO), are synthetic polymers with thermoreversible behavior in 
aqueous solutions and widely used in pharmaceutical systems. They are available in different 
molecular weights with commercial name pluronics. Among pluronics, F127 is widely 
explored for drug delivery due to its thermo-reversible gelation properties, ability to 
solubilize hydrophobic solutes and to form micellar structure (incorporate both hydrophilic 
and hydrophobic drugs)and extending drug release and non-toxicity. Moreover, Pluronic 
F127 gels have also exhibited improvement in wound healing by stimulating expression of 
vascular epithelial growth factor and (VEGF) and transforming growth factor (TGF-β1)16-17. 
The aim of this study was comparing the antibacterial activity of vaginal lactobacilli 
metabolites loaded chitosan and Pluronic F127 hydrogel formulations againstPseudomonas 
aeruginosa. 
MATERIALS AND METHODS 
Lactobacillus sp. Isolates  
In this study, metabolites of the sevenL. gasseri, two L. crispatus, and one L. helveticus 
vaginal isolateswhich were previously identified in terms of species-level by analyzing the 
16S rRNA gene sequence and found effective against some test bacteria were used3.  
Obtaining metabolites 
Lactobacillus isolates grown on Rogosa Agar for 24-48 hours were inoculated into tubes 
containing De Man-Rogosa Sharpe Broth(Merck, Germany), at 37 ºC, under anaerobic 
conditions for 72 hours. After the incubation period, cells were removed by centrifugation 
(12000 g, 10 min, 4 ºC). The cell-free supernatantswere filter-sterilized (0.45 µm pore size) 
(Minisart, Germany)3, 18.  
Preparation of Chitosan and Pluronic Hydrogels  
Chitosan was dissolved in 1% acetic acid solution at room temperature with continuous 
mechanical stirring to obtain a 1% (w/w) solution13. Metabolite loaded chitosan hydrogel was 
made by adding 20 µl of supernatant into the chitosan solution.  
Pluronic F127 hydrogel (20 wt%) was prepared by gradually adding under magnetic stirring 
at 4 0C Pluronic F127 powder to distilled water. The temperature was maintained at 4 0C until 
complete dissolution of Pluronic F127 powder19. Metabolite containing Pluronic F127 
hydrogel was prepared by gradually adding 20 µl of supernatant into the Pluronic F127 
solution under magnetic stirring at 4 0C. 
Antimicrobial Activity Test 
The antimicrobial activities of the metabolite loaded hydrogel formulations were investigated 
against Pseudomonas aeruginosaATCC 27853 using Agar Spot Method20. Test bacteria 
culture grown for 18-24 hours, adjusted to McFarland 0.5, were inoculated onto Mueller-
Hinton Agar plate with sterile swabs. 20 μL of each of metabolite loaded hydrogel 
formulations and supernatant were dropped equidistantly onto media inoculated with test 
bacteria. Lactobacilli supernatants as positive control were used. All the plates were 
incubated at 37 ºC for 18-24 hours, under aerobic conditions. After incubation, the growth 
inhibition in Agar Spot Method was considered as a positive effect. 
  
RESULTS and DISCUSSION 
Five L. gasseri, one L. crispatus, and L. helveticus metabolites loaded chitosan hydrogel 
formulationswere found to be effective against P. aeruginosa. Although chitosan alone had 
antibacterial activity, it was found that the metabolites loaded chitosan formulations showed 
better antibacterial activity.  
Besides that, Pluronic F127 hydrogel formulation didn’tprovide antimicrobial activity 
asmetabolites couldn’t release from hydrogel formulation. This is thought to be due to the 
high viscosity of the Pluronic F127 hydrogel with a concentration of 20%. When we compare 
these two hydrogel formulations, we observed that hydrogel formulation prepared by using 
chitosan released effective metabolites and therefore antimicrobial activity could be 
observed. 
CONCLUSION 
In conclusion, the antibacterial effect of vaginal Lactobacillus metabolites loaded chitosan 
hydrogel formulation suggests that effective metabolite loaded this formulation could be used 
in the treatment of P. aeruginosa skin infections. However, further investigations are needed 
to develop a pharmaceutical product. 
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